Two Sigma Advisers’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-58,900
| Closed | -$12.4K | – | 2643 |
|
|
2023
Q2 | $12.4K | Buy |
58,900
+600
| +1% | +$126 | ﹤0.01% | 2341 |
|
|
2023
Q1 | $9.33K | Sell |
58,300
-73,600
| -56% | -$11.8K | ﹤0.01% | 2543 |
|
|
2022
Q4 | $73.2K | Sell |
131,900
-192,700
| -59% | -$107K | ﹤0.01% | 2329 |
|
|
2022
Q3 | $386K | Sell |
324,600
-156,500
| -33% | -$186K | ﹤0.01% | 1956 |
|
|
2022
Q2 | $304K | Sell |
481,100
-349,400
| -42% | -$221K | ﹤0.01% | 2118 |
|
|
2022
Q1 | $947K | Sell |
830,500
-223,000
| -21% | -$254K | ﹤0.01% | 1666 |
|
|
2021
Q4 | $2.37M | Sell |
1,053,500
-639,700
| -38% | -$1.44M | 0.01% | 1107 |
|
|
2021
Q3 | $5.79M | Buy |
1,693,200
+527,800
| +45% | +$1.81M | 0.02% | 717 |
|
|
2021
Q2 | $3.49M | Buy |
1,165,400
+390,800
| +50% | +$1.17M | 0.01% | 1033 |
|
|
2021
Q1 | $2.5M | Buy |
774,600
+553,200
| +250% | +$1.79M | 0.01% | 1161 |
|
|
2020
Q4 | $469K | Buy |
+221,400
| New | +$469K | ﹤0.01% | 1887 |
|
|
2017
Q1 | – | Sell |
-52,763
| Closed | -$71K | – | 2502 |
|
|
2016
Q4 | $71K | Sell |
52,763
-2,700
| -5% | -$3.63K | ﹤0.01% | 2287 |
|
|
2016
Q3 | $87K | Sell |
55,463
-41,100
| -43% | -$64.5K | ﹤0.01% | 2144 |
|
|
2016
Q2 | $128K | Buy |
+96,563
| New | +$128K | ﹤0.01% | 1943 |
|
|
2015
Q1 | – | Sell |
-37,663
| Closed | -$636K | – | 2239 |
|
|
2014
Q4 | $636K | Buy |
+37,663
| New | +$636K | ﹤0.01% | 1295 |
|